Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
Clinical trial NCT01459419 · UNKNOWN
Trial details
- NCT number
- NCT01459419
- Sponsor
- Inspira Medical AB
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.